Rx ODI SRL
The score of Rx ODI shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +22 % Total assets -7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rx ODI's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 64,450 € | ||||
| Equity | 409,486 € | ||||
| Cash | 228,449 € | ||||
| EBITDA | 235,078 € | ||||
| Total assets | 431,889 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 17 Jun 2022
Rx ODI's financial analysis
- Solvency94.8%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rx ODI
Rx ODI's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0508.776.777
- VAT number
- BE0508776777
- Peppol
- Registered · 0208:0508776777 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2012
- Registered office
- 4020 Liège
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Rx ODI (SRL) has been based in Liège since 2012, active in: medical specialists activities. For 2025, it reports a net profit of 64,450 € and equity of 409,486 €; its revenue is not published. Its solvency stands at 94.8%, above the median of its sector (65.0%).
Companies similar to Rx ODI
Companies in the same business, of comparable size and area, outside its group.
- Lento Labs Manufacture of household and sanitary goods and of toilet requisites Antwerp · balance sheet 432,069 €
- Duchesne Wholesale of textiles Soumagne · balance sheet 431,639 €
- Projet 922 Business and other management consultancy activities Brussels · balance sheet 431,568 €
- Lafina Manufacture of plastics in primary forms Wielsbeke · balance sheet 432,251 €
- AZIMUTH Technisch Studiebureau Manufacture of basic pharmaceutical products Maarkedal · balance sheet 432,313 €
- Chimaydical Chimay · balance sheet 431,886 €
- AVL Immobilière Liège · balance sheet 431,839 €
Frequently asked questions about Rx ODI
What is the revenue of Rx ODI?
Rx ODI files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rx ODI?
In Belgium, the VAT number is the company number prefixed with BE: BE0508776777 for Rx ODI, if the company is VAT-registered. Its company number (CBE) is 0508.776.777.
Where is the registered office of Rx ODI?
According to the CBE register, the registered office of Rx ODI is in 4020 Liège.
What is the equity of Rx ODI?
At the close of the 2025 financial year, the equity of Rx ODI amounts to 409,486 €, a solvency of 94.8% of total assets.
Who manages Rx ODI?
The register lists 1 active mandates at Rx ODI. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rx ODI
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →